NGM Bio Announces Closing of Tender OfferGlobe Newswire • 19 days ago
SAN FRANCISCO, April 05, 2024 (GLOBE NEWSWIRE) -- NGM Biopharmaceuticals, Inc. ( NGM Bio ) (Nasdaq: NGM), a biotechnology company focused on discovering and developing transformative therapeutics...
Share to Feed
AgeX Therapeutics (NYSE:AGE Get Free Report) and NGM Biopharmaceuticals (NASDAQ:NGM Get Free Report) are both small-cap medical companies, but which is the superior stock? We will...
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates CTLT, HRT, NGM, SDPI SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates CTLT, HRT, NGM, SDPI PR Newswire NEW YORK, March 22, 2024 NEW YORK, March 22...
NEW YORK, March 22, 2024 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may seek...
NEW YORK, March 21, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...
SOUTH SAN FRANCISCO, Calif., March 19, 2024 (GLOBE NEWSWIRE) -- NGM Biopharmaceuticals, Inc. (NGM Bio) (Nasdaq: NGM), a biotechnology company focused on discovering and developing transformative...
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates FREE, HRT, NGM, KNTE SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates FREE, HRT, NGM, KNTE PR Newswire NEW YORK, March 18, 2024 NEW YORK, March 18...
Raymond James cut shares of NGM Biopharmaceuticals (NASDAQ:NGM Free Report) from an outperform rating to a market perform rating in a research note released on Tuesday, MarketBeat Ratings...
NEW YORK, March 16, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates EGLE, X, PGTI, NGM SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates EGLE, X, PGTI, NGM PR Newswire NEW YORK, March 13, 2024 NEW YORK, March 13, 2024...